Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

1003743

registered interest
date	09/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cannabis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what plans he has to increase the (a) knowledge and (b) awareness among GPs of the benefits of medicinal cannabis.
tabling member constituency	Gower
tabling member printed	Tonia Antoniazzi
uin	189815
answer	answer is ministerial correction date of answer 20/11/2018 answer text <p>The Government has rescheduled cannabis-based products for medicinal use from Schedule 1 to Schedule 2 of the Misuse of Drugs Regulations 2001. Doctors on the specialist register of the General Medical Council may now prescribe these products where there might be potential benefit to individual patients. General practitioners will not be able to prescribe but the Government has commissioned the National Institute for Health and Care Excellence to produce guidance for all clinicians by October 2019.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 20/11/2018 11:38:40 answering member 4067 label Biography information for Steve Brine
tabling member	4623 label Biography information for Tonia Antoniazzi

943843

registered interest
date	18/07/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cannabis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what discussions he is having with NHS England to ensure that consultants are aware of the licensing process for access to medical cannabis.
tabling member constituency	Gower
tabling member printed	Tonia Antoniazzi
uin	165715
answer	answer is ministerial correction date of answer 23/07/2018 answer text <p>The Department is working with NHS England and equivalents in the devolved administrations to ensure that cannabis-based medicinal products are sourced and supplied where a licence is granted. In the longer-term, prescribing guidance will be developed following any decision to reschedule these products.</p><p> </p><p>Guidance on the licensing process for access to cannabis and cannabis-based medicinal products is available on the Home Office Gov.uk website.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 23/07/2018 15:04:17 answering member 4067 label Biography information for Steve Brine
tabling member	4623 label Biography information for Tonia Antoniazzi

933959

registered interest
date	02/07/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Analgesics
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 1 February 2017 to Question 60736 on Analgesics, what the cost to the NHS was of purchasing opioid painkillers in 2016.
tabling member constituency	Gower
tabling member printed	Tonia Antoniazzi
uin	159704
answer	answer is ministerial correction date of answer 09/07/2018 answer text <p>The net ingredient cost to the National Health Service of opioid painkillers of items prescribed in the United Kingdom and dispensed in England for 2016 is provided in the following table.</p><table><tbody><tr><td><p>Year</p></td><td><p>Primary Care</p></td><td><p>Secondary Care</p></td><td><p>Total</p></td></tr><tr><td><p>2016</p></td><td><p>292,085,464</p></td><td><p>33,551,583</p></td><td><p>325,637,046</p></td></tr></tbody></table><p> </p><p>Source: Prescription Cost Analysis; IQVIA 2018: Hospital Pharmacy Audit Index</p> answering member constituency Winchester answering member printed Steve Brine question first answered 09/07/2018 15:50:36 answering member 4067 label Biography information for Steve Brine
tabling member	4623 label Biography information for Tonia Antoniazzi

869408

registered interest
date	22/03/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cannabis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether he plans to grant licences for medicinal cannabis products; and if he will make a statement.
tabling member constituency	Gower
tabling member printed	Tonia Antoniazzi
uin	133922
answer	answer is ministerial correction date of answer 29/03/2018 answer text <p>The Medicines and Healthcare products Regulatory Agency (MHRA) is the United Kingdom Agency responsible for the regulation of medicines used in the UK.</p><p> </p><p>The MHRA has not received any marketing authorisation (licence) applications for a medicinal product that contains raw cannabis, for the treatment of any condition in the UK.</p><p> </p><p>If a licence application for a medicinal product containing raw cannabis is received, the MHRA would assess the data submitted to ensure that the product is safe, has efficacy in the purpose claimed for it, is manufactured to the necessary quality standards and that there is a positive balance of benefits over any risks before approval of the licence.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 29/03/2018 11:18:22 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4623 label Biography information for Tonia Antoniazzi